Larvol Delta - Alzamend-Neuro-Announces-Initiation-Date-of-First-Phase-II-Clinical-Trial-of-AL001-to-take-Place-at-Massachusetts-General-Hospital

LISPRO (lithium/proline/salicylate) - Alzamend Neuro

https://www.globenewswire.com/news-release/2025/02/25/3031992/0/en/Alzamend-Neuro-Announces-Initiation-Date-of-First-Phase-II-Clinical-Trial-of-AL001-to-take-Place-at-Massachusetts-General-Hospital.html

Feb 25, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next